EP1218392A4 - Gene die proteine kodieren welche prognostische, diagnostische, präventive, therapeutische und andere verwendungen besitzen - Google Patents

Gene die proteine kodieren welche prognostische, diagnostische, präventive, therapeutische und andere verwendungen besitzen

Info

Publication number
EP1218392A4
EP1218392A4 EP00946957A EP00946957A EP1218392A4 EP 1218392 A4 EP1218392 A4 EP 1218392A4 EP 00946957 A EP00946957 A EP 00946957A EP 00946957 A EP00946957 A EP 00946957A EP 1218392 A4 EP1218392 A4 EP 1218392A4
Authority
EP
European Patent Office
Prior art keywords
prognostic
preventive
diagnostic
therapeutic
genes encoding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP00946957A
Other languages
English (en)
French (fr)
Other versions
EP1218392A1 (de
Inventor
Christopher C Fraser
John D Sharp
Nicholas Wrighton
Paul S Myers
Andrew D J Goodearl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Millennium Pharmaceuticals Inc
Original Assignee
Millennium Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharmaceuticals Inc filed Critical Millennium Pharmaceuticals Inc
Publication of EP1218392A1 publication Critical patent/EP1218392A1/de
Publication of EP1218392A4 publication Critical patent/EP1218392A4/de
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
EP00946957A 1999-09-10 2000-06-30 Gene die proteine kodieren welche prognostische, diagnostische, präventive, therapeutische und andere verwendungen besitzen Ceased EP1218392A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US393996 1989-08-15
US39399699A 1999-09-10 1999-09-10
PCT/US2000/018174 WO2001018016A1 (en) 1999-09-10 2000-06-30 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses

Publications (2)

Publication Number Publication Date
EP1218392A1 EP1218392A1 (de) 2002-07-03
EP1218392A4 true EP1218392A4 (de) 2003-04-09

Family

ID=23557106

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00946957A Ceased EP1218392A4 (de) 1999-09-10 2000-06-30 Gene die proteine kodieren welche prognostische, diagnostische, präventive, therapeutische und andere verwendungen besitzen

Country Status (3)

Country Link
EP (1) EP1218392A4 (de)
AU (1) AU6063900A (de)
WO (1) WO2001018016A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030162955A1 (en) * 1998-03-17 2003-08-28 Lionel Chalus Isolated mammalian membrane protein genes; related reagents
EP1224201A4 (de) * 1999-10-29 2005-03-02 Human Genome Sciences Inc 32 vom menschen abgesonderte proteine
US20020037827A1 (en) * 2000-03-06 2002-03-28 Kai Wang Novel matrix metalloproteinase (MMP-25) expressed in skin cells
US7271240B2 (en) 2001-03-14 2007-09-18 Agensys, Inc. 125P5C8: a tissue specific protein highly expressed in various cancers
AU2008202217B2 (en) * 2002-08-16 2012-07-26 Agensys, Inc. Nucleic acids and corresponding proteins entitled 191PAD12(b) useful in treatment and detection of cancer
AU2003243151A1 (en) * 2002-08-16 2004-03-03 Agensys, Inc. Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
GB0224436D0 (en) * 2002-10-21 2002-11-27 Univ Cambridge Tech Polypetides methods and means
US9446029B2 (en) 2010-07-27 2016-09-20 Colorado State University Research Foundation Use of NK-1 receptor antagonists in management of visceral pain
LT2621526T (lt) 2010-09-29 2018-09-25 Agensys, Inc. Antikūno-vaisto konjugatai (adc), kurie jungiasi prie 191p4d12 baltymų

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000042201A2 (en) * 1999-01-11 2000-07-20 Incyte Pharmaceuticals, Inc. Human peptidases
WO2001016335A2 (fr) * 1999-08-31 2001-03-08 Pierre Fabre Medicament Nouvelle metalloprotease matricielle mmp-27 homologue aux stromelysines
WO2001040466A2 (en) * 1999-12-01 2001-06-07 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2001066766A2 (en) * 2000-03-06 2001-09-13 Darwin Molecular Corporation A matrix metalloproteinase (mmp-25) expressed in skin cell
WO2001090326A2 (en) * 2000-05-22 2001-11-29 Pharmacia & Upjohn Company Novel matrix metalloproteinases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63503514A (ja) * 1986-06-17 1988-12-22 セルテク・リミテツド タンパク質の製法

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000042201A2 (en) * 1999-01-11 2000-07-20 Incyte Pharmaceuticals, Inc. Human peptidases
WO2001016335A2 (fr) * 1999-08-31 2001-03-08 Pierre Fabre Medicament Nouvelle metalloprotease matricielle mmp-27 homologue aux stromelysines
WO2001040466A2 (en) * 1999-12-01 2001-06-07 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2001066766A2 (en) * 2000-03-06 2001-09-13 Darwin Molecular Corporation A matrix metalloproteinase (mmp-25) expressed in skin cell
WO2001090326A2 (en) * 2000-05-22 2001-11-29 Pharmacia & Upjohn Company Novel matrix metalloproteinases

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 23 November 1998 (1998-11-23), STRAUSBERG R.: "ql60g12.x1 Soares_NhHMPu_S1 Homo sapiens cDNA clone IMAGE:1876774 3' similar to TR:Q28397 Q28397 MATRIX METALLOPROTEINASE 3. ; mRNA sequence.", XP002219261, Database accession no. AI273586 *
DATABASE GENESEQ [online] 24 October 2001 (2001-10-24), BAKER KP, ET AL.: "Human cDNA sequence encoding for PRO5992 polypeptide", XP002219263, Database accession no. AAS21339 *
DATABASE GENESEQ [online] 24 October 2001 (2001-10-24), BAKER KP, ET AL.: "Human PRO5992 polypeptide sequence", XP002219262, Database accession no. AAU12267 *
See also references of WO0118016A1 *

Also Published As

Publication number Publication date
AU6063900A (en) 2001-04-10
EP1218392A1 (de) 2002-07-03
WO2001018016A1 (en) 2001-03-15

Similar Documents

Publication Publication Date Title
ZA983148B (en) Modified TNFÓ, DNA encoding such modified TNFÓ and vacines comprising said TNFÓ and DNA.
EP1210416A4 (de) Gene, welche für proteine zur diagnostischen, vorbeugenden und therapeutischen verwendung kodieren
EP1218392A4 (de) Gene die proteine kodieren welche prognostische, diagnostische, präventive, therapeutische und andere verwendungen besitzen
HUP0104825A3 (en) Genes and proteins, and their use
AU1138699A (en) Dna demethylase, therapeutic and diagnostic uses thereof
EP1194534A4 (de) GENE, DIE FüR PROTEINE KODIEREN, WELCHE DIAGNOSTISCHE, PRäVENTIVE, THERAPEUTISCHE UND ANDERE ANWENDUNGEN HABEN
EP1240198A4 (de) Gene, die für proteine mit prognostischen, diagnostischen, präventiven, therapeutischen und anderen anwendungen kodierenden
AU2769101A (en) Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
MXPA02002767A (es) Usos terapeuticos del polipeptido m3.
WO2001011039A3 (de) Sequenzvarianten des menschlichen 1-adrenozeptorgens und ihre verwendung
AU5904400A (en) Novel genes encoding proteins having diagnostic, preventive, therapeutic, and other uses
WO2001029084A3 (en) Novel human proteins and polynucleotides encoding the same
AU9362801A (en) A novel polypeptide, a human protein 10 containing a group and the polynucleotide encoding the polypeptide
AU1510801A (en) A novel polypeptide, a human s100 calcium binding protein 21 and the polynucleotide encoding the polypeptide
AU8953401A (en) A novel polypeptide, a human protein 16.83 ftsh and the polynucleotide encoding the polypeptide
ZA200005845B (en) Gene encoding syntaxin interacting protein.
AU5799500A (en) Human alpha 1,2-mannosidase
AU2001274923A1 (en) Novel human thrombospondin-like proteins and polynucleotides encoding the same
AU4632201A (en) A novel polypeptide, a human rs3 protein 12 and the polynucleotide encoding the polypeptide
AU8953201A (en) A novel polypeptide, a human dna methylation protein and the polynucleotide encoding the polypeptide
AU1508501A (en) A novel polypeptide, a human calcium binding protein 42 and the polynucleotide encoding the polypeptide
AU3010199A (en) Human leupaxin polypeptide and dna encoding it, their uses
AU5309500A (en) Novel human genes and proteins encoded thereby
AU4726901A (en) Novel human proteins and polynucleotides encoding the same
AU8948801A (en) A novel polypeptide, a human transformer-2-beta protein 29.15 and the polynucleotide encoding the polypeptide

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020322

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RIN1 Information on inventor provided before grant (corrected)

Inventor name: MYERS, PAUL, S.

Inventor name: WRIGHTON, NICHOLAS

Inventor name: SHARP, JOHN, D.

Inventor name: GOODEARL, ANDREW, D., J.

Inventor name: FRASER, CHRISTOPHER, C.

A4 Supplementary search report drawn up and despatched

Effective date: 20030219

17Q First examination report despatched

Effective date: 20050225

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20070614